This tenth edition of ‘Drugs and addictions, key data’ updates the available data on addiction and the use of psychoactive substances, including drugs legally available to adults and illicit drugs.
This report details the practice of gambling in France, traces its developments since 2019 and addresses the problem of excessive gambling.
In total, 731 collections of psychoactive products were carried out under the OFDT's SINTES system in 2023, an increase of 17% compared to 2022.
The NOVURC survey (New Profiles of Regular Cannabis Users), focused on adults regularly using cannabis, highlights the diversity of use practices and the motivations behind consumption.
10 thematic workbooks describing the national situation on drugs in France in 2023.
This briefing paper from the French Monitoring Centre for Drugs and Drug Addiction (OFDT) provides an overview of the supply, uses, and the social and health consequences of alcohol consumption in France in 2023.
This briefing paper presents an overview and traces the main developments in the chemsex phenomenon in France over the past fifteen years.
In France, half of 17-year-olds have tried cigarettes, and nearly a third have tried cannabis. How do parents deal with this reality? The ARAMIS 2 survey questions parents of young consumers about parental control over their use.
The results of the ASTRACAN survey (For a strategic analysis of cannabis regulation policies) focus on regulatory practices following the legalisation of cannabis for “recreational” use in three American jurisdictions: Washington State, Oregon, and California.
This briefing paper aims to identify trends, and emerging and/or less widespread phenomena in the use of illicit drugs in Martinique in order to contribute to the understanding and knowledge of their developments in the longer term.
The OFDT presents the results of a survey on professional practices and care pathways for alcohol users within three medical addiction microstructures (MSMA).
The French gambling market confirmed its growth trend in 2023.
The illegal production of synthetic drugs (e.g. amphetamines, MDMA/ecstasy, methamphetamine) poses significant environmental risks, including soil and water contamination.
Issue 164 of Tendances presents the first results of EROPP 2023 for adults aged 18 to 64. It aims to describe the levels of use —and their changes since 2017— of the main illicit drugs consumed in France in 2023, as well as the levels of use of poppers and, for the first time, nitrous oxide.
The 2022-2023 National Adolescent Health and Substance Use Survey in Middle and High Schools (EnCLASS) interviewed a representative sample of pupils enrolled in high schools about their health, lifestyle habits, and possible use of psychoactive substances.
OFDT has published its annual report on tobacco smoking and tobacco cessation in 2023 in France.
At the request of public authorities, OFDT and Santé publique France have taken stock of available public data pertaining to the tobacco supply for smokers in France, between 2014 and 2022.
Results of the ESSPRI survey evidence a significant exposure to psychoactive substances among adult male inmates in mainland France, regardless of sentences lengths, irrespective of prison type and criminal status (awaiting trial or convicted).
The end of adolescence is the window of opportunity to try out gambling, the early and repetitive practice of which is likely to lead to problem gambling, much as the use of psychoactive substances.
The Tabatraj survey, conducted with approximately 70 participants who have recently quit smoking revealed that there are various and accumulative reasons for giving it up. Over time, smokers make several attempts to stop, and adjust their chosen cessation strategies